The new Alzheimer’s drug is about $50,000 too expensive ...Middle East

The US Food and Drug Administration (FDA) approved a treatment to slow down the progression of Alzheimer’s disease. The medication, developed by Biogen, will be marketed with the name Aduhelm for a list price of $56,000 a year.This is the first drug approved for the disease—which affects about 6 million Americans and an estimated 44 million people worldwide—in 20 years, and it’s already highly controversial.Of the 10 independent experts called to share their assessment of the drug with the FDA, nine recommend not approving it, and one concluded its benefits were unclear. Of the two studies presented by Biogen, one showed no benefits, and the other modest ones. Both, however, had concerning s

Hence then, the article about the new alzheimer s drug is about 50 000 too expensive was published today ( Tuesday 08/06/2021 - 11:45 PM ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( The new Alzheimer’s drug is about $50,000 too expensive )

Last updated : 08 June 2021 clock 11:45 PM

Also on site :

The new Alzheimer’s drug is about $50,000 too expensive ...Middle East

China’s Edge in the AI Race May Come Down to Power

Ministry of Education of Jordan begins transformative national literacy initiative using Amira Learning

Malaysia’s Petronas to Boost Exploration to Maintain Domestic Output

Nvidia’s Campaign to Sell AI Chips to China Finally Pays Off

Pepperstone domineert de Global Forex Awards: Vier grote overwinningen luiden 2026 in

Higher Refining Margins Push Valero’s Q4 Profit above Estimates

OmniTaaS recognized as 'Emerging Leader' in MarketsandMarkets' latest 360Quadrant for the RFID Market

Reliance Industries Slashes Russian Crude Imports Under U.S. Sanctions Pressure

Pennsylvania Selects InVita's Track-Kit as Statewide Sexual Assault Kit Tracking System

Geoforce Acquires AssetLink Global to Expand Leadership in Rugged and Reliable Asset Tracking and Intelligence

Bandwidth to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

Citgo Buys Venezuelan Oil for the First Time Since 2019 Sanctions

New Charter Technologies Appoints Michelle Curtis as Chief Revenue Officer

Brent Breaks $70 After Trump Threatens Iran With Military Force

Concerto Biosciences Signs Development and Commercialization Agreement with Sacco System to Advance Next-Generation Microbial Ingredient Discovery